Skip to main content Accessibility help
×
Hostname: page-component-5d59c44645-l48q4 Total loading time: 0 Render date: 2024-02-20T16:26:08.569Z Has data issue: false hasContentIssue false

Chapter 24 - Viral Hepatitis

Published online by Cambridge University Press:  23 July 2018

Rachel L. Chin
Affiliation:
University of California, San Francisco School of Medicine
Bradley W. Frazee
Affiliation:
University of California, San Francisco School of Medicine
Zlatan Coralic
Affiliation:
University of California, San Francisco
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Bernal, W. and Wendon, J. Acute liver failure. N. Engl. J. Med. 2014; 370(12): 1170–1.Google ScholarPubMed
Cross, T. J., Rizzi, P., Horner, M., et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J. Med. Virol. 2008; 80(2): 277–82.CrossRefGoogle ScholarPubMed
Falade-Nwulia, O., Suarez-Cuervo, C., Nelson, D. R., et al. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Annals Intern. Med. 2017; 166(9): 637–48.CrossRefGoogle ScholarPubMed
Jacobsen, K. H. and Koopman, J. S. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol. Infect. 2004; 132(6): 1005–22.CrossRefGoogle ScholarPubMed
Kamal, S. M. Acute hepatitis C: a systematic review. Am. J. Gastroenterol. 2008; 103(5): 1283–97; quiz 1298.CrossRefGoogle Scholar
Kamar, N., Izopet, J., Tripon, S., et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N. Engl. J. Med. 2014; 370(12): 1111–20.CrossRefGoogle ScholarPubMed
Khuroo, M. S., Khuroo, M. S., and Khuroo, N. S. Hepatitis E: discovery, global impact, control and cure. World J. Gastroenterol. 2016; 22(31): 7030–45.Google Scholar
Lee, W. M., Hynan, L. S., Rossaro, L., et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137(3): 856–64, 864 e1.CrossRefGoogle ScholarPubMed
Lee, W. M., Stravitz, R. T., and Larson, A. M. Introduction to the Revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011. Hepatology. 2012; 55(3): 965–7.CrossRefGoogle Scholar
Lok, A. S. and McMahon, B. J. Chronic hepatitis B: update 2009. Hepatology 2009; 50(3): 661–2.CrossRefGoogle ScholarPubMed
Polson, J. and Lee, W. M. American Association for the Study of Liver D. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41(5): 1179–97.CrossRefGoogle Scholar
Price, J. An update on hepatitis B, D, and E viruses. Top. Antivir. Med. 2014; 21(5): 157–63.Google ScholarPubMed
Renou, C., Afonso, A. M., and Pavio, N. Foodborne transmission of hepatitis E virus from raw pork liver sausage, France. Emerg. Infect. Dis. 2014; 20(11): 1945–7.CrossRefGoogle ScholarPubMed
Romeo, R., Del Ninno, E., Rumi, M., et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009; 136(5): 1629–38.CrossRefGoogle ScholarPubMed
Smith, B. D., Morgan, R. L., Beckett, G. A., et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Morb. Mortal. Wkly. Rep. 2012; 61(RR-4): 132.Google ScholarPubMed
Terrault, N. A., Lok, A. S. F., McMahon, B. J., et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018; 67(4): 1560–99.CrossRefGoogle Scholar
Thomas, D. L., Yarbough, P. O., Vlahov, D., et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J. Clin. Microbiol. 1997; 35(5): 1244–7.CrossRefGoogle Scholar
Wedemeyer, H., Yurdaydin, C., Dalekos, G. N., et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N. Engl. J. Med. 2011; 364(4): 322–31.CrossRefGoogle ScholarPubMed
Zhu, F. C., Zhang, J., Zhang, X. F., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376(9744): 895902.CrossRefGoogle ScholarPubMed
Davern, T. J. Fulminant hepatic failure in Bayless, T. M and Diehl, A. M (eds.), Advanced Therapy in Gastroenterology and Liver Disease, 5th edn. (Ontario: BC Decker, 2006), pp. 629–37.Google Scholar
Pratt, D. S. and Kaplan, M. M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med. 2000; 342(17): 1266–71.CrossRefGoogle ScholarPubMed
Recommendations for testing, managing, and treating hepatitis C from the American Association for the Study of Liver Diseases and Infectious Diseases Society of America, www.hcvguidelines.org (accessed November 13, 2017).Google Scholar
Davern, T. J. Fulminant hepatic failure in Bayless, T. M and Diehl, A. M (eds.), Advanced Therapy in Gastroenterology and Liver Disease, 5th edn. (Ontario: BC Decker, 2006), pp. 629–37.Google Scholar
Pratt, D. S. and Kaplan, M. M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med. 2000; 342(17): 1266–71.CrossRefGoogle ScholarPubMed
Recommendations for testing, managing, and treating hepatitis C from the American Association for the Study of Liver Diseases and Infectious Diseases Society of America, www.hcvguidelines.org (accessed November 13, 2017).Google Scholar

Additional Readings

Davern, T. J. Fulminant hepatic failure in Bayless, T. M and Diehl, A. M (eds.), Advanced Therapy in Gastroenterology and Liver Disease, 5th edn. (Ontario: BC Decker, 2006), pp. 629–37.Google Scholar
Pratt, D. S. and Kaplan, M. M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med. 2000; 342(17): 1266–71.CrossRefGoogle ScholarPubMed
Recommendations for testing, managing, and treating hepatitis C from the American Association for the Study of Liver Diseases and Infectious Diseases Society of America, www.hcvguidelines.org (accessed November 13, 2017).Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×